DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Kevin Ronald Sayer
CEOKevin Ronald Sayer
Employees
10,300
Employees10,300
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
10,300
Employees10,300

DXCM Key Statistics

Market cap
31.37B
Market cap31.37B
Price-Earnings ratio
60.81
Price-Earnings ratio60.81
Dividend yield
Dividend yield
Average volume
3.18M
Average volume3.18M
High today
$82.09
High today$82.09
Low today
$79.61
Low today$79.61
Open price
$81.50
Open price$81.50
Volume
4.97M
Volume4.97M
52 Week high
$117.27
52 Week high$117.27
52 Week low
$57.52
52 Week low$57.52

DXCM News

Simply Wall St 5d
DexCom Insiders Sell US$11m Of Stock, Possibly Signalling Caution

Over the past year, many DexCom, Inc. ( ) insiders sold a significant stake in the company which may have piqued investors' interest. When analyzing insider tra...

DexCom Insiders Sell US$11m Of Stock, Possibly Signalling Caution

Analyst ratings

83%

of 30 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.